𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of cervical dystonia with botulinum toxin

✍ Scribed by Joseph Jankovic


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
70 KB
Volume
19
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Comparison of clinical rating scales in
✍ Dr. Daniel Tarsy πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 217 KB

## Abstract Seventy‐six consecutive patients with cervical dystonia (CD) treated with botulinum toxin were assessed with the Tsui rating scale, the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS), and a global scale of improvement. Tsui, TWSTRS, and TWSTRS subscale scores all showed sig

Comparison of treatment of tardive dysto
✍ Dr. Allison Brashear; Walter T. Ambrosius; George J. Eckert; Eric R. Siemers πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 337 KB

To compare clinical parameters of patients treated with botulinum toxin type A (BTX) for treatment of idiopathic cervical dystonia (ICD) and for tardive cervical dystonia (TCD), we studied 156 patients (149 with ICD and 7 with TCD) who were treated with serial injections of BTX over 5 years. We hypo

Long-term botulinum toxin treatment incr
✍ Inger Marie Skogseid; Jo RΓΈislien; BjΓΈrgulf Claussen; Emilia Kerty πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 153 KB

## Abstract We examined the impact of cervical dystonia (CD) and long‐term botulinum toxin (BTX) treatment on employment status. Data on employment status at onset of CD, at initiation of BTX treatment, and at evaluation of long‐term treatment were obtained from 62 CD patients aged 31–66 years (med

Extensor truncal dystonia: Successful tr
✍ Cynthia L. Comella; Kathleen M. Shannon; Jeana Jaglin πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 335 KB

## Abstract Patients with truncal extension dystonia, manifested by involuntary back arching, often associated with pain and severe motor disability, have not consistently responded to pharmacologic agents. We evaluated 4 women and 1 man (mean age, 41.8 years; dystonia duration, 9.8 years) with sev